MoneyGram is partnering with Ripple to get into the crypto game.
The money transfer company says the tie-up could help send funds more cheaply and quickly. And one journalist believes the third-largest cryptocurrency offers a benefit over the alternatives.
“Ripple doesn’t have miners,” Fortune writer Jeff John Roberts told Cheddar. “You’re not relying on someone to mine a new block, and pack in the transaction, so they can do it instantly.”
MoneyGram will test using Ripple’s XRP coin to send money over its payment network xRapid. The news helped Ripple rebound after an early morning sell-off, which was in response to South Korean officials saying they are planning to ban trading in crypto. Immediately after the announcement, the price surged about 15 percent.
Roberts said the deal is a moment of truth for Ripple, since many blockchain watchers doubted the coin can get financial institutions to use its system.
He says the value will continue to surge if it can also prove it will lower the cost of money transfers.
For full interview [click here](https://cheddar.com/videos/moneygram-and-ripple-teaming-up).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
